New Hope for Kidney Disease: Vera Therapeutics’ Atacicept Advances Through Accelerated FDA Path

Vera Therapeutics has taken a major step toward transforming treatment for immunoglobulin A nephropathy (IgAN), submitting a Biologics License Application to the U.S. Food and Drug Administration through the Accelerated…

Continue Reading New Hope for Kidney Disease: Vera Therapeutics’ Atacicept Advances Through Accelerated FDA Path